Idelalisib plus bendamustine and rituximab improves the outcome of relapsed/refractory CLL
Current research at Weill Cornell and the New York Genome Center
Is CLL curable today?
Persistence of preleukemic clones in acute myeloid leukemia (AML) complete remission
Conversations doctors must have with CLL patients